Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report

Creative Commons License

Sonmez I., KÖŞGER F.

TURK PSIKIYATRI DERGISI, vol.27, no.1, pp.63-66, 2016 (SSCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.5080/u10109
  • Journal Name: TURK PSIKIYATRI DERGISI
  • Journal Indexes: Social Sciences Citation Index (SSCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.63-66
  • Keywords: Synthetic cannabinoid receptor agonist, psychotic disorder, cannabis, SPICE, PHARMACOLOGY, CONSUMPTION, DRUGS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Synthetic cannabinoid receptor agonists (SCRA) has become one of the most abused substances, recently. JWH-018 street name known as Bonzai is one of the most abused substances in Turkish Republic of Northern Cyprus. The most common symptoms in cases reported with synthetic cannabis use are agitation, angry, paranoia and reference delusions, disorientation, seizure and nausea. Although the effects are very similar to cannabis, stimulant effects are more likely in SCRA use. In preparations containing SCRA do not contain cannabinidol agent which is reported to reduce the psychotic effects of the cannabis. This may explain the relationship between SCRA and psychotic disorders. We aimed to discuss a brief psychotic disorder associated with SCRA use and treatment which is less reported in the literature in this case report.